Latest filing published 20 Apr 2012 for SERACARE LIFE SCIENCES INC.
No signal scores available.
This profile gathers the share dealings of Ronald Dilling in Seracare Life Sciences Inc. In total, 11 filings cover trades dated from 1 July 2009 to 20 April 2012.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 20 April 2012, reports a transaction in Seracare Life Sciences Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations